Insider Trading & Ownership - ENANTA PHARMACEUTICALS INC (ENTA)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for ENANTA PHARMACEUTICALS INC
Goto 0, 1, 2, 3, 4, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-07-11
Sale
2024-07-15
5:29 pm
ENANTA PHARMACEUTICALS INCENTARottinghaus Scott T.
Chief Medical Officer
11,945$15.97$190,747102,342
(Direct)
View
2024-06-17
Sale
2024-06-17
8:38 pm
ENANTA PHARMACEUTICALS INCENTAKieffer Tara Lynn
Chief Product Strategy Officer
7,266$12.33$89,59032,341
(Direct)
View
2023-12-13
Sale
2023-12-15
8:08 pm
ENANTA PHARMACEUTICALS INCENTAVance Terry
Director
15,295$9.12$139,4905,800
(Direct)
View
2023-12-05
Sale
2023-12-06
8:31 pm
ENANTA PHARMACEUTICALS INCENTALuu Brendan
Sr. VP, Business Dev.
2,125$9.63$20,46436,736
(Direct)
View
2023-12-05
Sale
2023-12-06
8:29 pm
ENANTA PHARMACEUTICALS INCENTAKieffer Tara Lynn
Sr. VP, New Prod. Strat. & Dev
2,125$9.63$20,46437,260
(Direct)
View
2023-12-05
Sale
2023-12-06
8:26 pm
ENANTA PHARMACEUTICALS INCENTAGardiner Nathaniel S.
Sr. VP & General Counsel
2,412$9.63$23,228104,080
(Indirect
Direct)
View
2023-12-05
Sale
2023-12-06
8:24 pm
ENANTA PHARMACEUTICALS INCENTARottinghaus Scott T.
Sr. VP & CMO
534$9.63$5,14226,466
(Direct)
View
2023-12-05
Sale
2023-12-06
8:22 pm
ENANTA PHARMACEUTICALS INCENTAOr Yat Sun
Sr. VP, R&D & CSO
2,412$9.63$23,228370,695
(Direct)
View
2023-12-05
Sale
2023-12-06
8:19 pm
ENANTA PHARMACEUTICALS INCENTAMELLETT PAUL J
Sr. VP, Finance & Admin. & CFO
2,412$9.63$23,22893,549
(Direct)
View
2023-12-05
Sale
2023-12-06
8:17 pm
ENANTA PHARMACEUTICALS INCENTALuly Jay R.
President and CEO
7,230$9.63$69,625806,793
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-08-08
Tax Withholding
2024-08-09
5:24 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTARottinghaus Scott T.
Chief Medical Officer
1,467$17.2318,784
(Direct)
View
2024-08-08
Tax Withholding
2024-08-09
5:24 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTARottinghaus Scott T.
Chief Medical Officer
1,466$12.7318,784
(Direct)
View
2024-07-15
Exercise
2024-07-15
5:29 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTARottinghaus Scott T.
Chief Medical Officer
5,375$8.99102,342
(Direct)
View
2024-07-15
Exercise
2024-07-15
5:29 pm
N/A
2033-11-22
ENANTA PHARMACEUTICALS INCENTARottinghaus Scott T.
Chief Medical Officer
5,375$0102,342
(Direct)
View
2024-04-29
Option Award
2024-05-01
4:27 pm
N/A
2034-04-29
ENANTA PHARMACEUTICALS INCENTAKowalsky Matthew Paul
Chief Legal Officer
150,000$0150,000
(Direct)
View
2024-03-06
Option Award
2024-03-08
5:30 pm
N/A
2034-03-06
ENANTA PHARMACEUTICALS INCENTAVance Terry
Director
15,700$015,700
(Direct)
View
2024-03-06
Option Award
2024-03-08
5:27 pm
N/A
2034-03-06
ENANTA PHARMACEUTICALS INCENTARussell Lesley
Director
15,700$015,700
(Direct)
View
2024-03-06
Option Award
2024-03-08
5:23 pm
N/A
2034-03-06
ENANTA PHARMACEUTICALS INCENTAPeterson Kristine
Director
15,700$015,700
(Direct)
View
2024-03-06
Option Award
2024-03-08
5:19 pm
N/A
2034-03-06
ENANTA PHARMACEUTICALS INCENTAHata Yujiro S
Director
15,700$015,700
(Direct)
View
2024-03-06
Option Award
2024-03-08
5:15 pm
N/A
2034-03-06
ENANTA PHARMACEUTICALS INCENTAFOLETTA MARK G
Director
15,700$015,700
(Direct)
View
2024-03-06
Option Award
2024-03-08
5:12 pm
N/A
2034-03-06
ENANTA PHARMACEUTICALS INCENTACARTER BRUCE L A
Director
15,700$015,700
(Direct)
View
2024-02-26
Exercise
2024-02-27
6:31 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTAGardiner Nathaniel S.
Chief Legal Officer
5,187$8.99189,427
(Direct)
View
2024-02-26
Exercise
2024-02-27
6:31 pm
N/A
2033-11-22
ENANTA PHARMACEUTICALS INCENTAGardiner Nathaniel S.
Chief Legal Officer
5,187$0189,427
(Direct)
View
2024-02-12
Tax Withholding
2024-02-14
8:23 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTALuu Brendan
Chief Business Officer
973$12.4139,083
(Direct)
View
2024-02-12
Option Award
2024-02-14
8:23 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTALuu Brendan
Chief Business Officer
3,320$039,083
(Direct)
View
2024-02-12
Tax Withholding
2024-02-14
8:21 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTAKieffer Tara Lynn
Chief Product Strategy Officer
973$12.4139,607
(Direct)
View
2024-02-12
Option Award
2024-02-14
8:21 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTAKieffer Tara Lynn
Chief Product Strategy Officer
3,320$039,607
(Direct)
View
2024-02-12
Tax Withholding
2024-02-14
8:18 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTAGardiner Nathaniel S.
Chief Legal Officer
973$12.41106,427
(Direct)
View
2024-02-12
Option Award
2024-02-14
8:18 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTAGardiner Nathaniel S.
Chief Legal Officer
3,320$0106,427
(Direct)
View
2024-02-12
Tax Withholding
2024-02-14
8:15 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTARottinghaus Scott T.
Chief Medical Officer
755$12.4128,287
(Direct)
View
2024-02-12
Option Award
2024-02-14
8:15 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTARottinghaus Scott T.
Chief Medical Officer
2,576$028,287
(Direct)
View
2024-02-12
Tax Withholding
2024-02-14
8:12 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTAOr Yat Sun
Chief Scientific Officer
1,080$12.41373,295
(Direct)
View
2024-02-12
Option Award
2024-02-14
8:12 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTAOr Yat Sun
Chief Scientific Officer
3,680$0373,295
(Direct)
View
2024-02-12
Tax Withholding
2024-02-14
8:09 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTAMELLETT PAUL J
Chief Fin. & Admin Officer
973$12.4195,896
(Direct)
View
2024-02-12
Option Award
2024-02-14
8:09 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTAMELLETT PAUL J
Chief Fin. & Admin Officer
3,320$095,896
(Direct)
View
2024-02-12
Tax Withholding
2024-02-14
8:00 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTALuly Jay R.
President and CEO
1,584$12.41810,609
(Direct)
View
2024-02-12
Option Award
2024-02-14
8:00 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTALuly Jay R.
President and CEO
5,400$0810,609
(Direct)
View
2023-12-01
Tax Withholding
2023-12-05
9:24 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTALuu Brendan
Sr. VP, Business Dev.
753$9.4938,861
(Direct)
View
2023-12-01
Tax Withholding
2023-12-05
9:21 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTAKieffer Tara Lynn
Sr. VP, New Prod. Strat. & Dev
753$9.4939,385
(Direct)
View
2023-12-01
Tax Withholding
2023-12-05
9:19 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTAGardiner Nathaniel S.
Sr. VP & General Counsel
1,595$9.49106,492
(Direct)
View
2023-12-01
Tax Withholding
2023-12-05
9:15 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTAOr Yat Sun
Sr. VP, R&D & CSO
1,595$9.49373,107
(Direct)
View
2023-12-01
Tax Withholding
2023-12-05
9:11 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTAMELLETT PAUL J
Sr. VP, Finance & Admin. & CFO
1,595$9.4995,961
(Direct)
View
2023-12-01
Tax Withholding
2023-12-05
9:08 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTALuly Jay R.
President and CEO
5,787$9.49814,023
(Direct)
View
2023-11-22
Option Award
2023-11-22
5:12 pm
N/A
2033-11-22
ENANTA PHARMACEUTICALS INCENTALuu Brendan
Sr. VP, Business Dev.
83,000$083,000
(Direct)
View
2023-11-22
Option Award
2023-11-22
5:12 pm
N/A
2033-11-22
ENANTA PHARMACEUTICALS INCENTAKieffer Tara Lynn
Sr. VP, New Prod. Strat. & Dev
83,000$083,000
(Direct)
View
2023-11-22
Option Award
2023-11-22
5:12 pm
N/A
2033-11-22
ENANTA PHARMACEUTICALS INCENTAMELLETT PAUL J
Sr. VP, Finance & Admin. & CFO
83,000$083,000
(Direct)
View
2023-11-22
Option Award
2023-11-22
5:11 pm
N/A
2033-11-22
ENANTA PHARMACEUTICALS INCENTAGardiner Nathaniel S.
Sr. VP & General Counsel
83,000$083,000
(Direct)
View
2023-11-22
Option Award
2023-11-22
5:11 pm
N/A
2033-11-22
ENANTA PHARMACEUTICALS INCENTAOr Yat Sun
Sr. VP, R&D & CSO
86,000$086,000
(Direct)
View
2023-11-22
Option Award
2023-11-22
5:10 pm
N/A
2033-11-22
ENANTA PHARMACEUTICALS INCENTARottinghaus Scott T.
Sr. VP & CMO
86,000$086,000
(Direct)
View
2023-11-22
Option Award
2023-11-22
5:10 pm
N/A
2033-11-22
ENANTA PHARMACEUTICALS INCENTALuly Jay R.
President and CEO
264,000$0264,000
(Direct)
View
Goto 0, 1, 2, 3, 4, Next